Li, H.; Peyser, N.D.; Zeng, Y.; Ha, P.K.; Johnson, D.E.; Grandis, J.R.
NSAIDs Overcome PIK3CA Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical Models. Cancers 2022, 14, 506.
https://doi.org/10.3390/cancers14030506
AMA Style
Li H, Peyser ND, Zeng Y, Ha PK, Johnson DE, Grandis JR.
NSAIDs Overcome PIK3CA Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical Models. Cancers. 2022; 14(3):506.
https://doi.org/10.3390/cancers14030506
Chicago/Turabian Style
Li, Hua, Noah D. Peyser, Yan Zeng, Patrick K. Ha, Daniel E. Johnson, and Jennifer R. Grandis.
2022. "NSAIDs Overcome PIK3CA Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical Models" Cancers 14, no. 3: 506.
https://doi.org/10.3390/cancers14030506
APA Style
Li, H., Peyser, N. D., Zeng, Y., Ha, P. K., Johnson, D. E., & Grandis, J. R.
(2022). NSAIDs Overcome PIK3CA Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical Models. Cancers, 14(3), 506.
https://doi.org/10.3390/cancers14030506